All News

Scaling Up

Delivering on the Promise of Cell and Gene Therapy Distributed and Point-of-Care Manufacturing
31 July 2023
Delivering on the Promise of Cell and Gene Therapy Distributed and Point-of-Care Manufacturing
At Advanced Therapies Week 2023,
Vertex and Lonza Unite to Build Dedicated Facility for Type 1 Diabetes Cell Therapies
27 June 2023
Vertex and Lonza Unite to Build Dedicated Facility for Type 1 Diabetes Cell Therapies
Vertex and Lonza announce strategic
Anthony Nolan and MicrofluidX Partner to Revolutionize the Development of Cell and Gene Therapies
23 June 2023
Anthony Nolan and MicrofluidX Partner to Revolutionize the Development of Cell and Gene Therapies
MicrofluidX will be testing its
Yposkesi Expands with State-of-the-Art $60M Biomanufacturing Facility for Cell and Gene Therapies
22 June 2023
Yposkesi Expands with State-of-the-Art $60M Biomanufacturing Facility for Cell and Gene Therapies
Yposkesi doubles its viral vector
POPULAR NEWS ITEMS
Image
21 September 2023

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image
20 September 2023

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image
20 September 2023

The Cell & Gene Therapy Manufacturing Capacity Map

Development of a Robust Scalable Suspension Platform for AAV Manufacturing up to 2000L
20 June 2023
Development of a Robust Scalable Suspension Platform for AAV Manufacturing up to 2000L
This Briefing from Advanced Therapies
Ancillary Material Considerations for a Seamless Transition into GMP Manufacturing
16 May 2023
Ancillary Material Considerations for a Seamless Transition into GMP Manufacturing
This Briefing from Advanced Therapies
Cellular Origins Partners with ScaleReady for Cell Therapy Manufacturing
12 May 2023
Cellular Origins Partners with ScaleReady for Cell Therapy Manufacturing
Cellular Origins Partners with ScaleReady
How to Deliver a Biotech Facility 3 Years Faster Than Traditional Build Construction Methods
5 May 2023
How to Deliver a Biotech Facility 3 Years Faster Than Traditional Build Construction Methods
This Briefing from Advanced Therapies
Load more News
RECOMENDED TOPICS
Automation & Digitisation
Characterisation
CMC
GMP
Logistics
Partnering
Point of Care
Raw Materials
Scaling Up
Skills, Talent & Development
Supply Chain
POPULAR NEWS ITEMS
Image

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image

The Cell & Gene Therapy Manufacturing Capacity Map